Alprostadil (Caverject/MUSE) Cost in Vermont 2026

The 2026 Price Answer Starts With the Exact Product

“Alprostadil price” can refer to products that are not interchangeable. Caverject is alprostadil powder reconstituted for intracavernosal injection. Caverject Impulse is a dual-chamber delivery system. MUSE was a single-dose urethral suppository. A compounded injection may contain alprostadil alone or combine it with other ingredients, commonly called bimix or Trimix.

The current Caverject label on DailyMed lists 20-microgram and 40-microgram vial packages, while the Caverject Impulse label lists 10-microgram and 20-microgram dual-chamber systems. Those package differences affect both pharmacy price and included supplies.

MUSE requires a separate availability check. FDA's Drugs@FDA record for NDA 020700 lists its 125-, 250-, 500-, and 1,000-microgram urethral-suppository products as discontinued. The historical MUSE labeling remains useful for product and safety information, but an old label is not proof of current Vermont inventory. A page that quotes an ongoing monthly MUSE price without confirming an available National Drug Code can mislead patients.

Why We Do Not Publish a Made-Up “$600 per Month” Number

Neither FDA nor Vermont publishes a universal retail cash price for Caverject. “Monthly cost” also changes with a patient's prescribed frequency; the label does not direct every patient to use the same number of doses. A coupon-site snapshot from one pharmacy on one day is not a statewide average and may omit the office visit, supplies, or dispensing quantity.

Use a same-basis quote instead. Ask the pharmacy to provide:

• the exact product name and National Drug Code;
• vial or device strength and package quantity;
• cash price before and after any pharmacy discount;
• insurance price, including deductible and coinsurance;
• whether needles, syringes, diluent, and alcohol swabs are included;
• whether the item is in stock or must be ordered; and
• the date through which the quote is valid.

The current Caverject label states that supplies needed for the vial presentation are not supplied with it. That is a real cost difference, not a footnote. Caverject Impulse has different package contents, so a per-device comparison can be more useful than comparing headline package prices.

The HealthRX Vermont Cost Worksheet

Compare a 90-day total, not a promotional first fill:

1. Medication: pharmacy quote for the exact NDC and quantity.
2. Initial clinical visit: include the visit where the treatment is evaluated and the first injection is administered.
3. Teaching and titration: ask whether this is included in the first visit or billed separately.
4. Supplies: include every item not packaged with the selected presentation.
5. Follow-up: include any required reassessment during the same 90-day period.
6. Shipping: include temperature-controlled or expedited shipping only if the dispensing pharmacy actually requires it.
7. Reimbursement risk: keep cash, insurance, HSA/FSA, and manufacturer-assistance scenarios in separate columns until each is confirmed.

Then divide only by the number of uses the prescriber expects from that exact package. Do not choose a dose or use frequency to make the cost calculation look better. The FDA-posted Caverject labeling says the dose is individually titrated and should not be changed without the clinician.

Vermont Medicaid: Verify Before Assuming “Covered With PA”

The claim that Vermont Medicaid universally covers alprostadil for erectile dysfunction after failure of oral drugs is not supported by a current public source. Historical Vermont documents cannot establish a 2026 benefit, and a drug's absence or presence in an old preferred drug list does not prove a current member's coverage.

The May 2026 Vermont Medicaid General Billing and Forms Manual says drugs requiring prior authorization are identified on the current Preferred Drug List and that Vermont Medicaid pays only for medically necessary items. It does not establish an alprostadil-specific approval rule, a $1-to-$3 copay, or a guaranteed appeal timeline.

Before the prescription is filled, ask the dispensing pharmacy to run the exact NDC as a prospective claim and ask the prescriber's office to confirm any rejection code. If authorization is required, the provider should use the current Vermont Medicaid criteria and form identified by the current state billing manual. If the benefit excludes erectile-dysfunction drugs, prior authorization should not be described as a guaranteed path around that exclusion.

The result to record is one of four things: covered without authorization, covered after authorization, excluded, or unable to determine until a claim is submitted. Keep the transaction date and rejection or authorization reference number. That is stronger evidence than a generic statement that “Vermont Medicaid covers it.”

Medicare Part D: The Organic-Cause Claim Is Wrong

Basic Medicare Part D excludes a drug when it is used to treat sexual or erectile dysfunction. CMS's official erectile-dysfunction drug guidance says the exception applies when the drug is used for an FDA-approved condition other than sexual or erectile dysfunction. It does not create coverage merely because erectile dysfunction follows diabetes, prostate surgery, spinal cord injury, or another “organic” cause.

A Part D plan may offer an excluded drug as a supplemental benefit under enhanced coverage, but that is plan-specific under the CMS erectile-dysfunction drug policy. Ask the plan whether alprostadil for erectile dysfunction is included as a supplemental benefit and whether the exact product is on that supplemental formulary. Do not submit a different diagnosis simply to bypass the statutory exclusion.

Medicare Part B is a separate question. CMS treats alprostadil used for erectile dysfunction as a typical example of a drug that patients usually self-administer, which can affect payment when it is supplied incident to an outpatient service. The CMS self-administered-drug explanation is not a promise that a retail prescription will be covered under Part B.

Commercial Insurance in Vermont

Commercial coverage cannot be reduced to “Tier 3” or “Tier 4” across Blue Cross Blue Shield of Vermont, MVP, and Cigna. Plans use different formularies and exclusions, and employer plans can differ from individual-market plans.

Blue Cross Blue Shield of Vermont's current covered-medication page explicitly tells members to use the formulary that corresponds to the ID card and notes that some plans exclude medications used for sexual dysfunction. It also tells employer-plan members to check with their benefits administrator because their coverage may differ.

Ask these questions using the exact NDC:

• Is the drug excluded or merely nonpreferred?
• Is coverage under the pharmacy benefit or medical benefit?
• Is prior authorization, step therapy, or a network specialty pharmacy required?
• What are the deductible, copay or coinsurance, quantity limit, and days-supply rule?
• Does the plan cover the teaching visit and supplies separately?
• If excluded, is there an exception process, and what plan language controls it?

A formulary search result is a starting point. The member-specific plan document and a processed test claim are better evidence of the amount owed.

Pfizer Assistance: Check Caverject, Not a Generic Promise

Pfizer's current Caverject product page points patients to Pfizer RxPathways for insurance support, copay help, and possible free or reduced-cost medicine. The RxPathways eligibility tool is the appropriate place to check current help for Caverject.

Do not rely on copied claims such as “$0 copay,” “400% of the federal poverty level,” or a fixed annual benefit unless those terms appear in the current Caverject program materials presented to the applicant. Program eligibility, available assistance, insurance restrictions, and benefit limits can change. Save the dated eligibility result and confirm whether it applies to the exact Caverject package prescribed.

A manufacturer program applies to its eligible branded product. It should not be presented as a discount for a compounded formulation, and it cannot establish what a Vermont pharmacy will charge before assistance.

Compounded Alprostadil and Trimix Are a Different Comparison

A compounded alprostadil preparation is not simply a cheaper generic Caverject. Compounded drugs are not FDA-approved, and FDA does not review them before marketing for safety, effectiveness, or quality. FDA's compounding questions and answers explains those differences.

Section 503A describes conditions under which patient-specific pharmacy compounding may qualify for exemptions from certain federal requirements. It does not mean every compounded copy of a commercially available drug is permissible, and “503A” is not an FDA quality certification. FDA's 503A bulk-substance and compounding policy page should be read together with the prescription, exact formulation, and state pharmacy requirements.

If a clinician proposes compounded alprostadil or Trimix, obtain:

• the exact ingredients and concentrations;
• the dispensing pharmacy's legal name and license details;
• the total volume, beyond-use date, storage instructions, and supplies;
• the written cash price and refill requirements; and
• a clear explanation of why this formulation is being selected for this patient.

Do not assume Vermont Medicaid, Medicare, or a commercial plan reimburses a compounded product. Run the exact claim first. Do not use a “research chemical” seller as a price alternative to a licensed pharmacy.

Telehealth Can Start the Evaluation, but the Label Still Controls Training

Vermont's Board of Medical Practice says clinicians treating Vermont patients through telehealth must hold an appropriate Vermont credential. The Board's telemedicine policy says prescribing can occur through telemedicine when the indication, appropriateness, and safety are evaluated and documented to the same professional standard as in-person prescribing.

That does not erase product-specific instructions. The Caverject prescribing information says the first intracavernosal injections must be administered in the health care provider's office, with individual titration to the lowest effective dose, and that the patient must be trained and assessed before home use. A video visit may cover history and counseling, but a service that offers injection delivery without a plan for the labeled office dose and training has left out a material part of treatment.

The American Urological Association guideline likewise recommends an in-office injection test for men considering intracavernosal injection therapy. Its journal article is indexed under the exact title “Erectile Dysfunction: AUA Guideline”.

Clinical Value and Safety That Affect Total Cost

Alprostadil can be effective, but a pharmacy price is only one part of the decision. The six-month study of intracavernosal alprostadil is correctly indexed as “Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction”. It should not be used to promise that every patient will respond or to convert a study rate into a guaranteed value proposition.

The current Caverject label identifies penile pain as the most common adverse reaction and warns about prolonged erection or priapism, penile fibrosis, hypotension, injection-site bleeding in people taking anticoagulants, and risks from combining intracavernosal vasoactive drugs. It instructs patients to seek immediate medical assistance for an erection lasting longer than four hours.

Those requirements can add legitimate costs: the office titration visit, correct supplies, follow-up, and access to urgent care. They are not reasons to avoid treatment when it is appropriate; they are reasons to compare complete treatment pathways rather than the cheapest advertised vial.

The Best Vermont Buying Sequence

1. Ask the clinician which exact product and package is being considered and why.
2. Confirm that MUSE availability is not being assumed from historical labeling.
3. Obtain two or more written pharmacy quotes for the same NDC and quantity.
4. Run the exact claim through the current insurance benefit before purchase.
5. Check Pfizer RxPathways directly if Caverject is prescribed.
6. Add office titration, supplies, shipping, and follow-up to a 90-day total.
7. If a compounded option is proposed, compare it as a distinct product and pharmacy pathway.
8. Choose with the prescriber based on clinical fit, evidence, safety, and verified total cost, not an affiliate coupon headline.